 |
||||||||||||||||||
 |
|
 |
||||||||||||||||
 |
|
|
Management TeamExecutive Management
Science Management
Neal Gutterson, President and Chief Executive Officer Neal has been Chief Executive Officer since February, 2007. He joined Mendel June 2002 and served as VP, R&D, and then Chief Operating Officer, prior to his appointment as President & COO in December, 2005. Neal is a member of the Board of Directors. Neal has been involved in plant biotechnology since 1983, when he joined the fledgling biotechnology company AGS, to develop genetically improved microbial biocontrol agents. Before joining Mendel, he spent 18 years at DNAP, where he managed diverse research programs and corporate relationships, and then served as VP, R&D for several years. He is a named inventor on more than 2 dozen patents and pending applications,. Neal holds a Ph.D. in Biochemistry from the University of California, Berkeley, and a B.S. in Chemistry from Yale University. He also attended the Stanford Graduate School of Business for an executive education program. He serves as a member of the Food and Agriculture Section and the Industrial and Environmental Section Governing Boards of the Biotechnology Industry Organization. He also serves on the executive committee of SCRA, a program to support regulatory approval of biotech specialty crop products, and on the steering committee of CSBP, the Council for Sustainable Biomass Production. Ajay Sabherwal, Chief Financial Officer Ajay joined Mendel in March 2009. Ajay has been the Chief Financial Officer of rapidly growing companies for the last 10 years. During this time, Ajay has been involved in a significant number of capital market transactions including raising funds through Initial Public Offerings and managing the transition from small privately owned Company to a significant publicly owned one. Prior to Mendel, Ajay was the Chief Financial Officer of Aventine Renewable Energy, a leading producer and marketer of ethanol in the United States, from November 2005 to March 2009. He was Chief Financial Officer of Choice One Communications, a leading competitive telephone service provider in the North East and Midwestern United States, from September 1999 until November 2005. Prior to being a Chief Financial Officer, Ajay was an Equity Analyst in Canada for CIBC World Markets. During his career, Ajay has held positions at BZW Canada, Deloitte Consulting, AT&T Canada and Louis Dreyfus (U.K.). Ajay holds a B.E. in Mechanical Engineering and a M.Sc. in Economics, both from the Birla Institute of Technology and Science in Pilani, India. He also holds an M.B.A. from the Manchester Business School in Manchester, U.K.. Greg Ikonen, General Counsel Greg joined Mendel in December 2007 with over fifteen years' experience across a broad range of legal and business matters, including structuring and negotiating complex transactions, intellectual property counseling, and general corporate and litigation issues, with a focus on biotechnology companies. Greg previously served as general counsel at a Bay Area biotechnology company. Prior to that he was a partner in the Life Sciences Group at Heller Ehrman LLP, and a partner at Venture Law Group, a Silicon Valley law firm focused on venture-backed life sciences and technology companies. Greg holds a B.S. in Chemical Engineering from the University of Michigan, and a J.D. from Harvard Law School. Oliver J. Ratcliffe, Sr. Vice President, Research Oliver joined Mendel in June 1999. He was appointed to the position of Vice President of Research in December 2005, following a two year period as a research director. He is a named inventor on more than 30 issued patents and published patent applications and has authored a range of scientific papers on topics including developmental biology, the control of flowering, and the regulation of environmental stress responses in plants. Oliver holds a B.A. in Genetics from Cambridge University and a Ph.D. in Biological Sciences from the John Innes Centre at the University of East Anglia. Donald M. Panter, Sr. Vice President, BioEnergy Seeds With over 20 years of experience in agricultural research and business development, Dr. Panter has held positions in both public and private sectors; with specialization in the areas of plant breeding and biotechnology. Don joined Mendel Biotechnology, Inc. in early 2010 as Senior Vice President, Mendel BioEnergy Seeds and is responsible for product development and commercialization activities in the BioEnergy crops development program. With a focus on establishing cost-effective, renewable biofuels feedstocks for the liquid fuel and power generation industries, the BioEnergy Seeds team will fully-develop its ongoing breeding programs, while establishing seed production logistics and new product development activities for several BioEnergy crops initiatives. Prior to joining Mendel, Don was Senior V.P. for Crop Development at Targeted Growth, Inc. and President of Sustainable Oils, LLC, a joint venture between Targeted Growth, Inc and Green Earth Fuels, LLC. From 2005 through 2007, Dr. Panter was V.P. for Technology at Renewable Agricultural Energy, Inc. (RAE), a Boulder, CO based biofuels company where his responsibilities included production plant site selection, feedstocks procurement and risk management, and leading collaborative feedstocks research and development programs with biofuels industry participants. As V.P. and Chief Technology Officer for Emergent Genetics, Inc. (EGI) from 1999 until 2005, Don led the global research efforts for EGI.s seed companies in the U.S., Argentina, Brazil, Costa Rica, Greece, Spain, Turkey, South Africa and India. Prior to 1999, Dr. Panter held the position of V.P. for Research and Development at Stoneville Pedigreed Seed Company, a wholly-owned subsidiary of the Monsanto Company. Dr. Panter holds a B.S. in Agriculture, an M.S. in Plant Breeding and Genetics, and a Ph.D. in Plant Breeding and Genetics from the University of Tennessee, Knoxville. Aaron Schuchart, Vice President, Business Development Aaron joined Mendel in July 2007 with twenty years of experience in both the biotechnology and energy industries. Prior to Mendel, Aaron structured and negotiated many collaborations and alliances at Amgen, Inc where he was responsible for global outlicensing activities. Prior to Amgen, he held various positions in operations, finance, and business development at Atlantic Richfield Company. Aaron holds a BBA from Texas Tech University and an MBA from UCLA. Christopher Williams-Campbell, Vice President, Human Resources Chris joined Mendel in April 2008 with over 23 years of human resource experience. Chris has served in a variety of human resource and management positions in the transportation (UPS), pharmaceutical (ALZA), medical device (VOLCANO), and software (ABSO) industries. Chris holds a BA in History from the University of California, Davis. Joshua Armstrong, Sr. Director, Research Josh joined Mendel in August, 2004 and now directs chemical genetics and new technology development programs at Mendel. Josh was appointed to a Director position in January, 2008. Prior to joining Mendel, Josh was a post-doctoral fellow at the Plant Gene Expression Center in Albany CA, where he demonstrated one of the first applications of forward chemical genetics in Arabidopsis thaliana. He holds a Ph.D. in Chemistry from the University of California, Berkeley. Don Maszle, Director, Computational Biology Don joined Mendel in March of 2002 as a Bioinformatics Scientist responsible for establishing platforms for data management, statistics and microarray analysis. He now directs the Computational Biology group. Prior to Mendel, he was an integral part of the global Bioinformatics group at Aventis, and was a key collaborator researching the transmission of schistosomiasis in Sichuan, China while at the School of Public Health at Berkeley. Don brings 20 years of experience in computational biology, ranging from pharmacokinetic modeling to ecological risk assessment. He has a background in systems and control engineering and a Ph.D. in Bioengineering from the University of California, Berkeley. Peter Repetti, Director, Research Peter joined Mendel in June, 2002 and was appointed as a research director in January, 2008. Peter has extensive expertise in the areas of plant-pathogen interactions, abiotic stress tolerance and expression profiling and currently directs a systems biology program to develop high resolution maps of plant transcriptional networks. Prior to joining Mendel, Peter worked at DNA Plant Technology in Oakland, CA. He holds a Ph.D. from UC Berkeley in Plant Biology, where he studied the molecular signaling of plant defenses against bacterial pathogens. T. Lynne Reuber, Director, Research Lynne joined Mendel in 1998, and was appointed to the position of Research Director in 2002. She currently directs a research program aimed at elucidating the mode of action of transcription factor leads for trait areas including yield enhancement, abiotic stress tolerance, and disease resistance. Prior to joining Mendel, Lynne was a post-doctoral fellow at Harvard Medical School, working in the area of plant-pathogen interactions. She holds a Ph.D. in Biology from Massachusetts Institute of Technology. Lynne is a named inventor on over 30 published patents and patent applications, and has authored publications in the area of plant-microbe interactions and plant transcription factor biology.
|
 |
||||||||||||||||||||
